欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
BE/V/0024/002
药品名称
Clavucill 200mg/ 50mg
活性成分
amoxicillin 200.0 mg
clavulanic acid 50.0 mg
剂型
Tablet
上市许可持有人
V.M.D. nv/sa Hoge Mauw 900 BE-2370 Arendonk Belgium
参考成员国 - 产品名称
Belgium (BE)
Clavucill 200mg/ 50mg
互认成员国 - 产品名称
Germany (DE)
Amoxiclav-VMD 250 mg
Denmark (DK)
Clavucill
Netherlands (NL)
France (FR)
CLAVUCILL 200 MG/0 MG COMPRIMES POUR CHIENS
Spain (ES)
CLAVUCILL 200 MG/50 MG COMPRIMIDOS PARA PERROS
Portugal (PT)
Sweden (SE)
Clavucill
Poland (PL)
Romania (RO)
许可日期
2011/06/22
最近更新日期
2020/11/09
药物ATC编码
QJ01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
Label_en_clavucill_500mg_10 08 2019
Date of last change:2024/09/06
Final Product Information
|
Leaflet_clavucill_250mg_en Clean
Date of last change:2024/09/06
Final Product Information
|
Leaflet_clavucill_500mg_en Clean
Date of last change:2024/09/06
Final Product Information
|
Leaflet_clavucill_50mg_en Clean
Date of last change:2024/09/06
Final PL
|
Leaflet_en_clavucill_500mg_ 10 08 2019
Date of last change:2024/09/06
Final SPC
|
spc_en_clavucill_500mg_ 10 08 2019
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase